Nautilus Biotechnology, Inc.
NAUT
$1.01
$0.033.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 190.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 190.00K | -- | -- | -- | -- |
| Cost of Revenue | 15.00K | -- | -- | -- | -- |
| Gross Profit | 175.00K | -- | -- | -- | -- |
| SG&A Expenses | 6.33M | 6.42M | 5.85M | 5.87M | 6.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.95M | 16.12M | 15.42M | 15.47M | 17.10M |
| Operating Income | -15.76M | -16.12M | -15.42M | -15.47M | -17.10M |
| Income Before Tax | -14.47M | -14.70M | -13.78M | -13.57M | -15.03M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.47M | -14.70M | -13.78M | -13.57M | -15.03M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.47M | -14.70M | -13.78M | -13.57M | -15.03M |
| EBIT | -15.76M | -16.12M | -15.42M | -15.47M | -17.10M |
| EBITDA | -15.49M | -15.79M | -15.02M | -15.05M | -16.64M |
| EPS Basic | -0.11 | -0.12 | -0.11 | -0.11 | -0.12 |
| Normalized Basic EPS | -0.07 | -0.07 | -0.07 | -0.07 | -0.07 |
| EPS Diluted | -0.11 | -0.12 | -0.11 | -0.11 | -0.12 |
| Normalized Diluted EPS | -0.07 | -0.07 | -0.07 | -0.07 | -0.07 |
| Average Basic Shares Outstanding | 127.14M | 126.63M | 126.37M | 126.31M | 126.20M |
| Average Diluted Shares Outstanding | 127.14M | 126.63M | 126.37M | 126.31M | 126.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |